a. Examine the strategies that made it possible for G&D to gain control over its suppliers, distributors and rivals. b. Discuss the extermal factors (social and political) that might have made G&D very competitive in the pharmaceutical industry. c. As a Consultant, examine four (4) intemal strengths that will enable G&D maintain its competitive advantage in the pharmaceutical industry.

Principles Of Marketing
17th Edition
ISBN:9780134492513
Author:Kotler, Philip, Armstrong, Gary (gary M.)
Publisher:Kotler, Philip, Armstrong, Gary (gary M.)
Chapter1: Marketing: Creating Customer Value And Engagement
Section: Chapter Questions
Problem 1.1DQ
icon
Related questions
Question
CASE STUDY
G&D Ltd is a leading pharmaceutical company in Ghana. Upon conducting a SWOT analysis,
G&D is gaining some control over its suppliers, distributors and competitors. Unsurprisingly, the
company's stock price soared 15 percent in the first four weeks of 2018 while the overall stock
market declined 3 percent. G&D is headquartered in Cantonments, Accra and having 1,800 full-
time employees. The company acquired Ernest Chemist Ltd. for GHC5 million in 2017, adding
a broad manufacturing and distribution network for expanding in the generic medications and
medical devices market. Based in Tema, Tobinco Ltd is a manufacturer of several brands of
medical equipments and unprocessed medical supplies. D&G expects the Tobinco's acquisition
to contribute revenue of more than GHC2 million in 2018.
Following the outbreak of COVID-19 in Ghana with the first recorded case on March 12, 2020
when two infected travellers from Norway and Turkey landed at KIA, Ghana waged a war against
the deadly virus with staggering statistics; 81,245 confirmed cases; 74,047 recoveries; 6,614
active cases; 584 deaths; and 500+ new infections daily by February 2021, amidst restrictions
and various coping mechanisms.
Since then, the Government of Ghana has been exploring the possibility of securing a vaccine
locally. Meanwhile, leading pharmaceutical manufacturer G&D recently formed a partnership
with Merck Life Science to compete for the Food and Drugs Authority's new COVID-19
vaccination project that will replace the Oxford AstraZeneca COVID-19 Vaccine in Ghana. The
two partners are developing Johnson and Johnson vaccine based on G&D clinical laboratory
platform. Oxford AstraZeneca products are extensively used by the Ghana Health Service and
other health services organizations throughout West Africa in the last 30 years. The Ministry of
Health expects the first batch of the Johnson and Johnson vaccines to be available in January
2022. G&D revenues for fiscal fourth quarter (Q4) of 2019 increased 6.2 percent year-over-year,
partly due to the company's new Accessories division that was created after the acquisition of
Tobinco Ltd.
Required
a. Examine the strategies that made it possible for G&D to gain control over its suppliers,
distributors and rivals.
b. Discuss the extermal factors (social and political) that might have made G&D very
competitive in the pharmaceutical industry.
c. As a Consultant, examine four (4) intermal strengths that will enable G&D maintain its
competitive advantage in the pharmaceutical industry.
Transcribed Image Text:CASE STUDY G&D Ltd is a leading pharmaceutical company in Ghana. Upon conducting a SWOT analysis, G&D is gaining some control over its suppliers, distributors and competitors. Unsurprisingly, the company's stock price soared 15 percent in the first four weeks of 2018 while the overall stock market declined 3 percent. G&D is headquartered in Cantonments, Accra and having 1,800 full- time employees. The company acquired Ernest Chemist Ltd. for GHC5 million in 2017, adding a broad manufacturing and distribution network for expanding in the generic medications and medical devices market. Based in Tema, Tobinco Ltd is a manufacturer of several brands of medical equipments and unprocessed medical supplies. D&G expects the Tobinco's acquisition to contribute revenue of more than GHC2 million in 2018. Following the outbreak of COVID-19 in Ghana with the first recorded case on March 12, 2020 when two infected travellers from Norway and Turkey landed at KIA, Ghana waged a war against the deadly virus with staggering statistics; 81,245 confirmed cases; 74,047 recoveries; 6,614 active cases; 584 deaths; and 500+ new infections daily by February 2021, amidst restrictions and various coping mechanisms. Since then, the Government of Ghana has been exploring the possibility of securing a vaccine locally. Meanwhile, leading pharmaceutical manufacturer G&D recently formed a partnership with Merck Life Science to compete for the Food and Drugs Authority's new COVID-19 vaccination project that will replace the Oxford AstraZeneca COVID-19 Vaccine in Ghana. The two partners are developing Johnson and Johnson vaccine based on G&D clinical laboratory platform. Oxford AstraZeneca products are extensively used by the Ghana Health Service and other health services organizations throughout West Africa in the last 30 years. The Ministry of Health expects the first batch of the Johnson and Johnson vaccines to be available in January 2022. G&D revenues for fiscal fourth quarter (Q4) of 2019 increased 6.2 percent year-over-year, partly due to the company's new Accessories division that was created after the acquisition of Tobinco Ltd. Required a. Examine the strategies that made it possible for G&D to gain control over its suppliers, distributors and rivals. b. Discuss the extermal factors (social and political) that might have made G&D very competitive in the pharmaceutical industry. c. As a Consultant, examine four (4) intermal strengths that will enable G&D maintain its competitive advantage in the pharmaceutical industry.
Expert Solution
steps

Step by step

Solved in 4 steps

Blurred answer
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
Principles Of Marketing
Principles Of Marketing
Marketing
ISBN:
9780134492513
Author:
Kotler, Philip, Armstrong, Gary (gary M.)
Publisher:
Pearson Higher Education,
Marketing
Marketing
Marketing
ISBN:
9781259924040
Author:
Roger A. Kerin, Steven W. Hartley
Publisher:
McGraw-Hill Education
Foundations of Business (MindTap Course List)
Foundations of Business (MindTap Course List)
Marketing
ISBN:
9781337386920
Author:
William M. Pride, Robert J. Hughes, Jack R. Kapoor
Publisher:
Cengage Learning
Marketing: An Introduction (13th Edition)
Marketing: An Introduction (13th Edition)
Marketing
ISBN:
9780134149530
Author:
Gary Armstrong, Philip Kotler
Publisher:
PEARSON
MKTG 12:STUDENT ED.-TEXT
MKTG 12:STUDENT ED.-TEXT
Marketing
ISBN:
9781337407595
Author:
Lamb
Publisher:
Cengage
Contemporary Marketing
Contemporary Marketing
Marketing
ISBN:
9780357033777
Author:
Louis E. Boone, David L. Kurtz
Publisher:
Cengage Learning